PR Newswire - End of Day
- 53
PR Newswire
LONDON, United Kingdom, September 27
PR Newswire |
|
This is the END of day message for the PR Newswire Disclose service |
|
============================================================================== |
Disclaimer |
============================================================================== |
The content and accuracy of all information published on the Disclose service is the responsibility of the originating company or organisation and not PR Newswire or distributing companies. These companies include (but are not limited to) Thomson Reuters, Bloomberg, Hemscott, AFX and InvestEgate. However, PR Newswire shall use its reasonable efforts to correct any error or omission brought to its attention. |
Neither PR Newswire nor its distributing companies who place the information onto their services accept any responsibility for any use made of the information provided on the Disclose service and they will not be liable for any loss suffered thereby. However nothing shall limit any party's liability for fraud, death or personal injury caused by its negligence. |
All information contained in the Disclose service should be independently checked prior to any use or publication. |

- EQS-News: Viromed Medical AG: UMECO Group erwirbt exklusive Vermarktungsrechte für Kaltplasma-Medizinprodukte ViroCAP® und PulmoPlas® im asiatischen Raum
- EQS-Adhoc: Viromed Medical AG: UMECO Group erwirbt exklusive Vermarktungsrechte für Kaltplasma-Medizinprodukte ViroCAP® und PulmoPlas® im asiatischen Raum
- EQS-News: CHAPTERS gibt das Ergebnis des Rückkaufs der Anleihe 2020 bekannt
- Generalversammlung der Intershop Holding AG stimmt allen Anträgen des Verwaltungsrats zu
- EQS-Adhoc: PALFINGER AG: Start der konkreten Evaluierung für einen Verkauf eigener Aktien durch beschleunigtes Privat-Platzierungsverfahren
- HBM Healthcare Investments erwartet Jahresgewinn von CHF 19 Millionen für das Geschäftsjahr 2024/2025